In a significant shift, the National Institutes of Health (NIH) has released new guidance aimed at aligning its $39 billion grant portfolio with the priorities of the Trump administration. This seven-page document, titled “Reviewing Grants for Priority Alignment,” was disseminated to program officers responsible for managing grants, outlining a framework for assessing whether proposed grants meet the administration’s objectives.
The guidance not only instructs program officers on identifying grants that may not align with these priorities but also details the process for potentially terminating such grants. This move follows a public memo from NIH Director Jay Bhattacharya, reinforcing the administration’s intent to reshape the focus of biomedical research in the United States.
Experts have noted that this guidance could facilitate a more collaborative dialogue regarding grant terminations, allowing researchers to engage in discussions about their projects’ alignment with federal priorities. As the NIH implements these changes, the implications for the research community could be profound, potentially influencing the direction of future biomedical studies and funding opportunities.
Start your 7-day trial and see what the database can do →
